Atlas Trials

Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients With Mild to Moderately Active Ulcerative Colitis

Clinical trial NCT06488625 · RECRUITING

Trial details

NCT number
NCT06488625
Sponsor
University Hospital Schleswig-Holstein
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Ulcerative Colitis, Unspecified
Start date
2024-09-12
Primary completion
2027-10-01
Enrollment
459

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.